drugset / Trial / NCT01815957

Impact of Ranolazine on Coronary Microcirculatory Resistance

NCT01815957

NaSingle-groupOpen-labelTreatment

Summary

This study is being done to determine if Ranolazine treatment improves coronary microcirculation function among patients with coronary microcirculation dysfunction. We are also looking to learn if symptomatic improvement of chest pain during treatment with Ranalozine is related to improved coronary microcirculation function.

Timeline

Start
2012-05
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranolazine Small molecule 1000 mg Oral